Since the high number of CML cells in the blood might have influenced the results, in the present study, in order to more precisely characterize the immune status in chronic myeloid leukemia (CML), we analyzed both δRec-ψJα sjTRECs and TRBV-BD sjTRECs in sorted CD4+ and CD8+ T cells from CML patients. Here, CD4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.